ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.210,48
0,58%
S&P 500
5.187,70
0,13%
US Dollar vs BRL
5,0695
-0,14%
Bitcoin
62.980,00
-0,30%
Brent Oil
82,895
-0,69%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. AstraZeneca PLC (AZN)

  7. AstraZeneca PLC (AZN) Notícias

AZN

AstraZeneca (AZN)

AstraZeneca PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:AZN
DataHoraFonteTítuloCódigoCompanhia
01/11/202316:15AllPennyStocks.comBiotech Shares Soar After AstraZeneca Stake & Research CollaborationNYSE:AZNAstraZeneca PLC
28/06/202318:28Edgar (US Regulatory)Annual Report of Employee Stock Plans (11-k)NYSE:AZNAstraZeneca PLC
02/06/202313:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AZNAstraZeneca PLC
13/03/202317:38Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NYSE:AZNAstraZeneca PLC
02/03/202318:55Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NYSE:AZNAstraZeneca PLC
01/03/202308:27Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NYSE:AZNAstraZeneca PLC
24/01/202315:59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:AZNAstraZeneca PLC
11/11/202208:43TipRanksFDA Approves AstraZeneca’s (NASDAQ:AZN) Lung Cancer Combination TreatmentNYSE:AZNAstraZeneca PLC
10/11/202210:06TipRanksAstraZeneca (NASDAQ:AZN) Stock Rises on Upbeat Q3 Results, Guidance LiftNYSE:AZNAstraZeneca PLC
01/11/202206:08TipRanksAstraZeneca’s COVID-19 Vaccine Granted Full Approval in EUNYSE:AZNAstraZeneca PLC
16/09/202208:30TipRanksAstraZeneca (NASDAQ: AZN) Up on Positive Clinical Data and Evusheld ApprovalNYSE:AZNAstraZeneca PLC
08/07/202217:58Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:AZNAstraZeneca PLC
05/07/202210:31TipRanksHere’s How AstraZeneca Is Gearing up against LymphomaNYSE:AZNAstraZeneca PLC
27/06/202213:26TipRanksAstraZeneca’s Enhertu Wins Approval in EU by CHMPNYSE:AZNAstraZeneca PLC
10/06/202217:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NYSE:AZNAstraZeneca PLC
06/06/202204:50TipRanksAstraZeneca Breast Cancer Drug Shows Positive ResultsNYSE:AZNAstraZeneca PLC
04/05/202209:41TipRanksAstraZeneca (AZN) Receives a Buy from SVB SecuritiesNYSE:AZNAstraZeneca PLC
30/04/202200:49TipRanksAstraZeneca (AZN) Receives a Buy from Leerink PartnersNYSE:AZNAstraZeneca PLC
20/04/202219:12Business WireEVUSHELD™  significantly protected against symptomatic COVID-19 for at least six months in PROVENT Phase III trial in high-risk populationsNYSE:AZNAstraZeneca PLC
19/04/202208:03TipRanksAstrazeneca, Amoy Diagnostics to Develop Diagnostics ProgramsNYSE:AZNAstraZeneca PLC
06/04/202208:00Business WireULTOMIRIS® (ravulizumab-cwvz) demonstrated sustained improvements in functional activities and quality of life in adults with generalized myasthenia gravis through 60 weeksNYSE:AZNAstraZeneca PLC
24/03/202208:00Business WireAstraZeneca Announces New Partnership with The National Fish and Wildlife Foundation to Plant One Million TreesNYSE:AZNAstraZeneca PLC
21/03/202208:00Business WireEVUSHELD™ long-acting antibody combination retains neutralizing activity against Omicron variants including BA.2 in new independent studiesNYSE:AZNAstraZeneca PLC
03/03/202204:56TipRanksAstraZeneca Acquires Neurimmune’s Heart Failure Drug CandidateNYSE:AZNAstraZeneca PLC
22/02/202219:43Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NYSE:AZNAstraZeneca PLC
22/02/202219:19Edgar (US Regulatory)Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)NYSE:AZNAstraZeneca PLC
21/02/202213:15Business WireENHERTU® (fam-trastuzumab deruxtecan-nxki) Significantly Improved Both Progression-Free and Overall Survival in DESTINY-Breast04 Trial in Patients with HER2-Low Metastatic Breast CancerNYSE:AZNAstraZeneca PLC
14/02/202219:00Business WireLYNPARZA® (olaparib) plus Abiraterone Reduced Risk of Disease Progression by 34% vs. Standard-of-Care in 1st-Line Metastatic Castration-Resistant Prostate CancerNYSE:AZNAstraZeneca PLC
04/02/202211:08Edgar (US Regulatory)Schedule 13gNYSE:AZNAstraZeneca PLC
25/01/202207:27TipRanksAstraZeneca Announces Orphan Drug Designation for Eplontersen in the U.S.NYSE:AZNAstraZeneca PLC
 Apresentando as notícias mais relevantes sobre:NYSE:AZN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
NGRD3
Neogrid Participacoes ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
IRBR3
IRB BRASIL ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
AZEV4
AZEVEDO PN
BOV
PRIO3
PETRORIO ON
BOV
OIBR3
OI ON
BOV
HAGA3
HAGA ON
BOV
TPIS3
TRIUNFO PART ON
BOV
TELB4
TELEBRAS PN
BOV
BRKM5
BRASKEM PNA
BOV
GOLL4
GOL PN
BOV
VVEO3
CM Hospitalar ON
BOV
HOOT4
HOTEIS OTHON PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados